LEVOTIROXINA GSK
|
GlaxoSmithKline Biopharma
|
levotiroxina |
Terapéutica tiroidea |
100 mcg comp.x 50 | $23.775,02 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.032,59 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $12.611,35 AF $11.163,67 |
|
|
|
|
112 mcg comp.x 50 | $26.768,18 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.711,14 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $14.272,12 AF $12.496,06 |
|
|
|
|
125 mcg comp.x 50 | $29.861,68 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.878,95 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.878,35 AF $13.983,33 |
|
|
|
|
137 mcg comp.x 50 | $32.256,82 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.146,67 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.124,69 AF $15.132,13 |
|
|
|
|
150 mcg comp.x 50 | $33.553,08 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.244,81 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.760,34 AF $15.792,74 |
|
|
|
|
175 mcg comp.x 50 | $38.690,66 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.614,08 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $20.517,89 AF $18.172,77 |
|
|
|
|
25 mcg comp.x 50 | $7.556,39 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.377,88 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $1.733,08 |
|
|
|
|
50 mcg comp.x 50 | $11.383,74 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.406,25 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $5.560,43 |
|
|
|
|
75 mcg comp.x 50 | $15.957,25 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.769,50 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.538,77 AF $7.418,48 |
|
|
|
|
88 mcg comp.x 50 | $20.843,85 | (03/06/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.802,32 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.124,06 AF $9.719,79 |
|
|
|
|
|